Patient's Whole Process Follow-up Management(HOPE-1)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorQianfoshan Hospital
About this trial
Our project is going to explore whether management and follow-up of locally advanced/metastatic patients using the patient process management platform can prolong patient survival and improve patient quality of life.
Eligibility criteria
Qualifiers
Fully understand the research and voluntarily sign the informed consent form (ICF)
Male or female subjects who are over 18 years old (inclusive) at the time of signing the informed consent form.
The subject is diagnosed pathologically or cytologically with non-small cell lung cancer(NSCLC).
According to the 8th edition of the American Joint Committee on Cancer [AJCC], it is classified as stage IIB, stage III, stage IV NSCLC.
Disqualifiers
Patients with mental illness.
Presence of any other malignant tumor.
Patients who are expected to undergo radical surgery.
Currently participating in clinical trials.
Trial design
Treatments tested in this trial
- Patients' whole process follow-up and management platform
Treatment groups
1,268 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov